HTMC0435

HTMC0435 · Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HTMC0435, covering 2023-09-28 to 2023-09-28. Get the full timeline:

Most recent: Clinical Trial Update: HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer [Phase 1, Phase 2]